These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 34499008)

  • 1. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
    Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
    Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
    Song W; Yang K; Luo J; Gao Z; Gao Y
    Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.
    Sun Z; Sun X; Qin G; Li Y; Zhou G; Jiang X
    Epigenetics; 2023 Dec; 18(1):2242688. PubMed ID: 37538000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis.
    Zhao X; Yang Y; Sun BF; Shi Y; Yang X; Xiao W; Hao YJ; Ping XL; Chen YS; Wang WJ; Jin KX; Wang X; Huang CM; Fu Y; Ge XM; Song SH; Jeong HS; Yanagisawa H; Niu Y; Jia GF; Wu W; Tong WM; Okamoto A; He C; Rendtlew Danielsen JM; Wang XJ; Yang YG
    Cell Res; 2014 Dec; 24(12):1403-19. PubMed ID: 25412662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression.
    Shan HJ; Gu WX; Duan G; Chen HL
    Bioengineered; 2022 Apr; 13(4):8038-8050. PubMed ID: 35311620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
    Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
    J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
    Wu J; Wang X; Li X
    Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
    Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
    Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging.
    Jiang ZX; Wang YN; Li ZY; Dai ZH; He Y; Chu K; Gu JY; Ji YX; Sun NX; Yang F; Li W
    Cell Death Dis; 2021 Jul; 12(8):744. PubMed ID: 34315853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
    Ji FH; Fu XH; Li GQ; He Q; Qiu XG
    Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTO modifies the m6A level of MALAT and promotes bladder cancer progression.
    Tao L; Mu X; Chen H; Jin D; Zhang R; Zhao Y; Fan J; Cao M; Zhou Z
    Clin Transl Med; 2021 Feb; 11(2):e310. PubMed ID: 33634966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
    RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M6A RNA Methylation-Based Epitranscriptomic Modifications in Plasticity-Related Genes via miR-124-C/EBPα-FTO-Transcriptional Axis in the Hippocampus of Learned Helplessness Rats.
    Roy B; Ochi S; Dwivedi Y
    Int J Neuropsychopharmacol; 2022 Dec; 25(12):1037-1049. PubMed ID: 36161325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTO-mediated regulation of m6A methylation is closely related to apoptosis induced by repeated UV irradiation.
    Lin Y; Sun Y; Hou W; Chen X; Zhou F; Xu Q; Zheng Y
    J Dermatol Sci; 2024 Jun; 114(3):124-132. PubMed ID: 38749796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased N6-methyladenosine causes infertility is associated with FTO expression.
    Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
    J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells.
    Mo W; Chen Z; Zhang X; Dai G; Ma D; Pan J; Zhang X; Wu G; Fan W
    Arterioscler Thromb Vasc Biol; 2022 May; 42(5):644-658. PubMed ID: 35296150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new m6A methylation-related gene signature for prognostic value in patient with urothelial carcinoma of the bladder.
    Zheng B; Wang J; Zhao G; Chen X; Yao Z; Niu Z; He W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.
    Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H
    Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.